Skip to content
Residue Notes

Educational, research-use-only content. Not medical advice and not guidance for human use. Consult a qualified professional for health decisions.

← All notes

Compoundsneuropeptides

Melanotan-2 (MT-II)

Melanotan-2 (MT-II) is a cyclic lactam α-MSH analog and nonselective melanocortin receptor agonist studied in pigmentation, feeding, and sexual-function models; the research catalog lists it at https://onesourcepeptides.com/product/melanotan-2.

MT-II entered the melanocortin literature as a designed cyclic probe. Al-Obeidi et al., Journal of Medicinal Chemistry, 1989 (PMID 2555512) report a series of lactam-bridged α-MSH fragment analogs built around the His-D-Phe-Arg-Trp pharmacophore; the Asp5–Lys10 23-membered ring compound that became Melanotan-II showed roughly 100-fold higher melanotropic potency than α-MSH in the lizard-skin bioassay and prolonged residual activity relative to the linear hormone.

Early human pharmacology and central melanocortin work followed. Dorr et al., Life Sciences, 1996 (PMID 8637402) evaluated subcutaneous MT-II in a pilot phase-I study in healthy men and reported measurable increases in skin pigmentation after a short alternating-day course, alongside receptor-consistent observations such as stretching/yawning and intermittent erectile activity. In animal feeding models, Fan et al., Nature, 1997 (PMID 8990120) used MT-II as a melanocortin agonist to inhibit food intake and block the agouti obesity phenotype, establishing the peptide as a standard central MC3R/MC4R probe.

Sexual-function pharmacology extended the same scaffold. Wessells et al., Journal of Urology, 1998 (PMID 9679884) tested Melanotan-II in a double-blind crossover study in men with psychogenic erectile dysfunction and reported clinically apparent erections versus placebo under RigiScan monitoring. Related notes cover PT-141 (a related melanocortin agonist developed from the MT-II lineage) and Kisspeptin-10, and lot identity belongs on the certificate of analysis for the vial in hand (see Are research peptides third-party tested?). Melanotan-2 on the catalog is laboratory research supply only. This note summarizes published melanocortin-receptor research and is not dosing, reconstitution, or human-use guidance.

  1. PT-141 (Bremelanotide)

    PT-141 (bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist developed from the α-MSH analog Melanotan II and studied as a ligand of MC3R and MC4R in sexual-function models; the research catalog lists it at https://onesourcepeptides.com/product/pt-141.

  2. Kisspeptin-10 (GPR54 Agonist)

    Kisspeptin-10 is the biologically active C-terminal decapeptide of the KiSS-1 gene product and a potent agonist of the GPR54 (KISS1R) receptor, studied as the upstream switch that drives GnRH release and LH and FSH secretion in rodent and sheep models, and the research catalog lists it at https://onesourcepeptides.com/product/kisspeptin-10.

  3. Are research peptides third-party tested?

    A research peptide is third-party tested only when that lot's certificate of analysis names an outside laboratory; a note that a certificate is available on request is not itself a posted test.